Andrew B. Gladden

2.1k total citations
26 papers, 1.7k citations indexed

About

Andrew B. Gladden is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Andrew B. Gladden has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cell Biology. Recurrent topics in Andrew B. Gladden's work include Cancer-related Molecular Pathways (10 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Microtubule and mitosis dynamics (5 papers). Andrew B. Gladden is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Microtubule and mitosis dynamics (5 papers). Andrew B. Gladden collaborates with scholars based in United States, Canada and United Kingdom. Andrew B. Gladden's co-authors include J. Alan Diehl, Andrea I. McClatchey, Fengmin Lu, Jodi R. Alt, Mariusz A. Wasik, Eveline E. Schneeberger, Priya Aggarwal, Marco Giovannini, Marcello Curto and Ichiko Saotome and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Andrew B. Gladden

23 papers receiving 1.6k citations

Peers

Andrew B. Gladden

ONCOL

PRM

Alberto Martín Spain

Richele K. Rasmussen Australia

Barbara Nicke Germany

Matthias Drosten Spain

Reyno Delrosario United States

Verline Justilien United States

Yoon Jong Choi United States

Aidan G. Gilmartin United States

Dineli Wickramasinghe United States

Yoshimi Arima Japan

Alberto Martín Spain

Andrew B. Gladden

1.2k ×1.1

840 ×1.2

ONCOL

403 ×0.7

323 ×1.5

PRM

222 ×1.2

Citations per year, relative to Andrew B. Gladden Andrew B. Gladden (= 1×) peers Alberto Martín

Countries citing papers authored by Andrew B. Gladden

Since Specialization

Citations

This map shows the geographic impact of Andrew B. Gladden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew B. Gladden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew B. Gladden more than expected).

Fields of papers citing papers by Andrew B. Gladden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew B. Gladden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew B. Gladden. The network helps show where Andrew B. Gladden may publish in the future.

Co-authorship network of co-authors of Andrew B. Gladden

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew B. Gladden. A scholar is included among the top collaborators of Andrew B. Gladden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew B. Gladden. Andrew B. Gladden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Broaddus, Russell R., et al.. (2025). The Combined Effects of Urine Zinc, Cadmium, Mercury, Lead, and Copper on Endometrial Cancer Staging. International Journal of Environmental Research and Public Health. 22(2). 245–245.

Broaddus, Russell R., et al.. (2025). Differential Localization of β-Catenin Protein in CTNNB1 Mutant Endometrial Cancers Results in Distinct Transcriptional Profiles. Modern Pathology. 38(9). 100791–100791.

Sahoo, Subhransu S., Susmita G. Ramanand, Ileana Cuevas, et al.. (2025). A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis. Journal of Clinical Investigation. 135(16). 2 indexed citations

Atkins, Hannah, et al.. (2025). Loss of Ribosomal Protein L22 (RPL22) Expression Identifies a Transcriptional Subset of MLH1-Deficient Endometrial Cancers With Lower Numbers of Tumor-Associated Lymphocytes. Modern Pathology. 39(1). 100899–100899.

Broaddus, Russell R., et al.. (2022). Mechanisms of mutant β-catenin in endometrial cancer progression. Frontiers in Oncology. 12. 1009345–1009345. 22 indexed citations

Corkins, Mark E., et al.. (2021). The Wnt/PCP formin Daam1 drives cell-cell adhesion during nephron development. Cell Reports. 36(1). 109340–109340. 11 indexed citations

Corkins, Mark E., et al.. (2019). Divergent roles of the Wnt/PCP Formin Daam1 in renal ciliogenesis. PLoS ONE. 14(8). e0221698–e0221698. 13 indexed citations

Vue, Zer, et al.. (2018). The ERM family member Merlin is required for endometrial gland morphogenesis. Developmental Biology. 442(2). 301–314. 10 indexed citations

Williams, Erin, Alejandro Villar‐Prados, Jessica L. Bowser, Russell R. Broaddus, & Andrew B. Gladden. (2017). Loss of polarity alters proliferation and differentiation in low-grade endometrial cancers by disrupting Notch signaling. PLoS ONE. 12(12). e0189081–e0189081. 22 indexed citations

10.

Yang, Chih‐Chao, Hillary K. Graves, Iván M. Moya, et al.. (2015). Differential regulation of the Hippo pathway by adherens junctions and apical–basal cell polarity modules. Proceedings of the National Academy of Sciences. 112(6). 1785–1790. 100 indexed citations

11.

Ahmed, Zamal, Cristina Ivan, Jonathan Berrout, et al.. (2015). Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer. Oncogene. 35(17). 2186–2196. 26 indexed citations

12.

Longworth, Michelle S., James A. Walker, Endre Anderssen, et al.. (2012). A Shared Role for RBF1 and dCAP-D3 in the Regulation of Transcription with Consequences for Innate Immunity. PLoS Genetics. 8(4). e1002618–e1002618. 40 indexed citations

13.

Casaletto, Jessica B., et al.. (2012). Merlin/ERM proteins establish cortical asymmetry and centrosome position. Genes & Development. 26(24). 2709–2723. 49 indexed citations

14.

Benhamouche, Samira, Marcello Curto, Ichiko Saotome, et al.. (2010). Nf2 /Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes & Development. 24(16). 1718–1730. 205 indexed citations

15.

Lin, Douglas I., et al.. (2007). Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene. 27(9). 1231–1242. 61 indexed citations

16.

Gladden, Andrew B. & J. Alan Diehl. (2005). Location, location, location: The role of cyclin D1 nuclear localization in cancer. Journal of Cellular Biochemistry. 96(5). 906–913. 105 indexed citations

17.

Gladden, Andrew B., et al.. (2005). Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene. 25(7). 998–1007. 104 indexed citations

18.

Williams, Erin, Craig J. Burd, Andrew B. Gladden, et al.. (2004). A central domain of cyclin D1 mediates nuclear receptor corepressor activity. Oncogene. 24(3). 431–444. 56 indexed citations

19.

Gladden, Andrew B. & J. Alan Diehl. (2003). Cell cycle progression without cyclin E/CDK2. Cancer Cell. 4(3). 160–162. 61 indexed citations

20.

Alt, Jodi R., Andrew B. Gladden, & J. Alan Diehl. (2002). p21Cip1 Promotes Cyclin D1 Nuclear Accumulation via Direct Inhibition of Nuclear Export. Journal of Biological Chemistry. 277(10). 8517–8523. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact